… and NovoSeven® is on its way to becoming a blockbuster
{"Image DocumentName": "\u2026 and NovoSeven\u00ae is on its way to becoming a blockbuster", "Image ImageDescription": "A focused healthcare company within attractive therapy areas. Existing and new focus areas continue to offer attractive growth rates \u2026 \u2026 and NovoSeven\u00ae is on its way to becoming a blockbuster , Cancer. 5Y CAGR 31% CNS. GI. Million USD. Diabetes care. % CAGR Cardiovascular. Arthritis. Growth hormone. Respiratory. 5. Infectious disease Expected % CAGR Source: SG Cowen, IMS/BW and Novo Nordisk. 9.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}